Malignant Neoplasm of the Larynx B013
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-larynx-b013-c32
Rulebase for malignant neoplasm of the larynx
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-malignant-neoplasm-larynx
Alcohol consumption
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/alcohol-consumption
Being on land in Vietnam or in Vietnamese waters or consuming Vietnamese water
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/being-land-vietnam-or-vietnamese-waters-or-consuming-vietnamese-water
Cigar smoking
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/cigar-smoking
Cigarette smoking
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/cigarette-smoking
Exposure to a visible tobacco smoke haze
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/exposure-visible-tobacco-smoke-haze
Exposure to mustard gas
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/exposure-mustard-gas
Exposure to TCDD
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/exposure-tcdd
Inhaling respirable asbestos fibres
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/inhaling-respirable-asbestos-fibres
Inhaling smoke from the combustion of biomass or fossil fuels
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/inhaling-smoke-combustion-biomass-or-fossil-fuels
No appropriate clinical management for malignant neoplasm of the larynx
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/no-appropriate-clinical-management-malignant-neoplasm-larynx
Pipe smoking
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/pipe-smoking
Smoking tobacco products - material contribution
Current RMA Instruments
41 of 2022 | |
42 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Code: 161
- ICD-10-AM Code: C32
Brief description
The larynx is the upper part of the wind pipe and it includes the vocal cords. This SOP covers primary cancers arising in the larynx.
Confirming the diagnosis
The diagnosis requires confirmation with histology, with tissue obtained from a biopsy or surgery.
The relevant medical specialist is an ENT surgeon, head and neck surgeon, or oncologist.
Additional diagnoses covered by SOP
Malignant neoplasm of the glottis, supraglottis or subglottis
Conditions excluded from SOP
- Carcinoid of the larynx#
- Hodgkin’s lymphoma of the larynx*
- non-Hodgkin lymphoma of the larynx*
- Secondary/metastatic cancer involving the larynx (code to primary cancer site)
- soft tissue sarcoma of the larynx*
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting symptom is change in voice / persistent hoarseness. Other symptoms include, cough, haemoptysis (coughing blood), and strider (noisy, high pitched breathing). The condition may also be found after investigation of palpable lymph nodes in the neck.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management of the disease varies considerably with the type and stage of the disease and other factors. A delay in obtaining treatment could lead to a worsening of the prognosis.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-larynx-b013-c32/rulebase-malignant-neoplasm-larynx/smoking-tobacco-products-material-contribution